ArticleEcancermedicalscience2026
Optimising door-to-needle-time in children with febrile neutropenia in the paediatric emergency unit-a quality improvement study.
Article in Ecancermedicalscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and Background: Febrile Neutropenia is one of the leading causes of treatment-related mortality in children with malignancies. Door-to-needle-time (DTNT), defined as the time between arrival at hospital and antibiotic administration, of <60 minutes is considered standard of care in managing this oncological emergency. Objectives: In this quality improvement (QI) study, we aim to determine the proportion of children with febrile neutropenia (FN) receiving timely antibiotics in the Paediatric Emergency unit and improve this by 50% over 6 months using the Plan-Do-Study-Act framework. Secondary objectives included identifying factors associated with delays in achieving optimal DTNT and the impact of these delays on clinical outcomes. Methods: Baseline data of children less than 18 years of age on cancer chemotherapy presenting with neutropenic fever between January 2022 and June 2023 were collected ambispectively. A fishbone root cause analysis was performed. Interventions were planned and prioritised using a prioritisation matrix. QI measures were initiated subsequently in the form of the development and implementation of a validated clinical care pathway that described the triaging, clinical assessment, laboratory investigations, antibiotic dosing and patient disposition. Additionally, mannequin-assisted, followed by bedside training on chemoport handling, was performed. Post-intervention data, including the 6-months sustenance phase, were collected, and outcomes were analysed. Results: In the baseline, intervention and sustenance periods, 129, 80 and 47 episodes of FN, respectively, were documented. Median DTNT reduced by 50% from a baseline of 80 minutes interquartile range (IQR 65-105) to 40 minutes (IQR 30-40) post-intervention ( Conclusions: The median DTNT was significantly delayed in patients with FN. Inadequate knowledge and skills training, delays in vascular access and lack of implementation of standard protocols were identified as the key factors responsible for delays in antibiotic administration. QI strategies aimed at improving awareness and skill with rigorous training programs as well as clinical pathway implementation, significantly improved the time to antibiotic administration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.